These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Correction: Transition metal substituted sandwich-type polyoxometalates with a strong metal-C (imidazole) bond as anticancer agents. Zhao H; Tao L; Zhang F; Zhang Y; Liu Y; Xu H; Diao G; Ni L Chem Commun (Camb); 2020 Feb; 56(15):2364. PubMed ID: 32031558 [TBL] [Abstract][Full Text] [Related]
25. Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review. McCleskey TM; Buchner V; Field RW; Scott BL Rev Environ Health; 2009; 24(2):75-115. PubMed ID: 19658317 [TBL] [Abstract][Full Text] [Related]
26. Correction: Introduction of a mediator for enhancing photocatalytic performance via post-synthetic metal exchange in metal-organic frameworks (MOFs). Sun D; Liu W; Qiu M; Zhang Y; Li Z Chem Commun (Camb); 2015 Jul; 51(53):10765. PubMed ID: 26051283 [TBL] [Abstract][Full Text] [Related]
27. The comparative pulmonary toxicity of beryllium metal and beryllium oxide in cynomolgus monkeys. Haley PJ; Pavia KF; Swafford DS; Davila DR; Hoover MD; Finch GL Immunopharmacol Immunotoxicol; 1994 Nov; 16(4):627-44. PubMed ID: 7876465 [TBL] [Abstract][Full Text] [Related]
28. An immune model of beryllium-induced pulmonary granulomata in mice. Histopathology, immune reactivity, and flow-cytometric analysis of bronchoalveolar lavage-derived cells. Huang H; Meyer KC; Kubai L; Auerbach R Lab Invest; 1992 Jul; 67(1):138-46. PubMed ID: 1625444 [TBL] [Abstract][Full Text] [Related]
29. Correction: Inhibition of TLR1/2 dimerization by enantiomers of metal complexes. Liu LJ; Wang W; Zhong Z; Lin S; Lu L; Wang YT; Ma DL; Leung CH Chem Commun (Camb); 2017 Jan; 53(7):1325. PubMed ID: 28075430 [TBL] [Abstract][Full Text] [Related]
30. Correction: Revealing instability and irreversibility in nonaqueous sodium-O Sayed SY; Yao KP; Kwabi DG; Batcho TP; Amanchukwu CV; Feng S; Thompson CV; Shao-Horn Y Chem Commun (Camb); 2016 Dec; 53(2):460. PubMed ID: 27910967 [TBL] [Abstract][Full Text] [Related]
31. Correction: Vescalagin and castalagin reduce the toxicity of amyloid-beta42 oligomers through the remodelling of its secondary structure. Araújo AR; Camero S; Taboada P; Reis RL; Pires RA Chem Commun (Camb); 2021 Mar; 57(25):3158. PubMed ID: 33729246 [TBL] [Abstract][Full Text] [Related]